Unique ID issued by UMIN | UMIN000043815 |
---|---|
Receipt number | R000050004 |
Scientific Title | Single arm intervention study of the efficacy of the App for improving the lifestyle behavior in patients with Type 2 DM |
Date of disclosure of the study information | 2021/04/05 |
Last modified on | 2023/04/07 08:09:34 |
Single arm intervention study of the efficacy of the App for improving the lifestyle behavior in patients with Type 2 DM
Single arm intervention study of the efficacy of the App for improving the lifestyle behavior in patients with Type 2 DM
Single arm intervention study of the efficacy of the App for improving the lifestyle behavior in patients with Type 2 DM
Single arm intervention study of the efficacy of the App for improving the lifestyle behavior in patients with Type 2 DM
Japan |
Diabetes
Medicine in general | Endocrinology and Metabolism |
Others
NO
To develop the App that focuses on lifestyle improvement and evaluate its effects on type 2 diabetes.
Efficacy
weight, HbA1c, completion rate, utilization of App, improvement of blood test value
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Educational,Counseling,Training
Behavior,custom |
Lifestyle behavior improvement support by feedback from the App based on input data.
20 | years-old | <= |
Not applicable |
Male and Female
1) Patients aged over 20 years or older at the time of informed consent (both genders)
2) Patients with documented consent to participate in the study
3) Patients diagnosed with type 2 diabetes mellitus
4) Patients taking hypoglycemic drugs
5) Patients with HbA1c >= 6.5
6) Patients with a smartphone
1) A female subject who wishes to become pregnant, is pregnant, or is breastfeeding
2) Patients diagnosed with type 1 diabetes mellitus
3) Patients with a diagnosis of secondary diabetes mellitus
4) Patients with physician-determined advanced complications
5) Patients scheduled for hospitalization or surgery during this study
6) Patients with diseases other than diabetes mellitus who are instructed to restrict exercise
7) Patients who have participated in a clinical study or a post-marketing clinical study of another prescription drug or a medical device within 3 months, who are now participating in such a study, or who plan to participate in such a study during this study
8) Patients who have used a mobile application running on a smartphone terminal for the purpose of managing or assisting diabetes mellitus within the past 3 months
9) Medical institution staff or close relatives involved in this study
10) Other patients judged by the investigator to be inappropriate for inclusion in this study
100
1st name | Osamu |
Middle name | |
Last name | Tomonaga |
Tomonaga Clinic
Internal medicine
160-0022
4-2-23 Shinjuku, Shinjuku-ku, Tokyo
03-3351-0032
info@tomonaga-clinic.com
1st name | Koji |
Middle name | |
Last name | Tokutomi |
Mitsubishi Tanabe Pharma Corporation
Digital Transformation Department
103-8405
17-10, Nihonbashi-Koamicho Chuo-ku, Tokyo
03-6748-7637
tokutomi.koji@mr.mt-pharma.co.jp
Mitsubishi Tanabe Pharma Corporation
Mitsubishi Tanabe Pharma Corporation
Profit organization
Japan
Habitus Care Inc.
Tomonaga Clinic
4-2-23 Shinjuku, Shinjuku-ku, Tokyo
03-3351-0032
info@tomonaga-clinic.com
NO
医療法人社団ライフスタイル ともながクリニック(東京都)
2021 | Year | 04 | Month | 05 | Day |
Unpublished
58
Completed
2021 | Year | 03 | Month | 11 | Day |
2021 | Year | 03 | Month | 11 | Day |
2021 | Year | 03 | Month | 29 | Day |
2022 | Year | 10 | Month | 31 | Day |
2021 | Year | 04 | Month | 02 | Day |
2023 | Year | 04 | Month | 07 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050004